Eva Warlich

Biochemistry, Genetics and Molecular Biology · Life Sciences

4h-index504citations7works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CRISPR and Genetic Engineering(5), Pluripotent Stem Cells Research(4), 3D Printing in Biomedical Research(2), Virus-based gene therapy research(1), RNA Interference and Gene Delivery(1)

Publications7 total

Definition of reprogramming stages by <i>Oct4</i>-GFP activation and transgene silencing.
Figshare·2015Open Access
Oct4-GFP expression characteristics.
Figshare·2015Open Access
FAS-Based Cell Depletion Facilitates the Selective Isolation of Mouse Induced Pluripotent Stem Cells
PLoS ONE·2014· 1 citedOpen Access
Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells
Cytometry Part A·2011· 76 cited
Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular Reprogramming
Molecular Therapy·2011· 258 citedOpen Access
Protein transduction from retroviral Gag precursors
Proceedings of the National Academy of Sciences·2010· 135 citedOpen Access
Preparation of bioactive soluble human leukemia inhibitory factor from recombinant Escherichia coli using thioredoxin as fusion partner
Protein Expression and Purification·2010· 34 cited

Frequent Co-authors

Axel Schambach(7), Tobias Cantz(4), Dirk Wedekind(3), Silke Glage(3), Dominik Eckardt(3), Sebastian Knöbel(3), Johannes Kuehle(2), Tobias Maetzig(2), Melanie Galla(2), Hans R. Schöler(2), Dominik Lock(2), Andreas Bosio(2), Martijn H. Brugman(1), Adam Filipczyk(1), Stephan Halle(1), Hannes Klump(1), Christopher Baum(1), Timm Schroeder(1), Christine Voelkel(1), Daniela Zychlinski(1)